LONDON and NEW YORK, June 18, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) (“Tiziana” or the “Firm”), the U.S. and U.Okay. biotechnology firm that focuses on the invention and growth of novel molecules to deal with human illness in oncology and immunology, pronounces Gregor MacRae is standing down as a director of the Firm with instant impact.
Gabriele Cerrone, Chairman of Tiziana, mentioned “I thank Gregor for his contribution to the Board and the Firm and need him effectively in his different pursuits. We’re at the moment within the strategy of recruiting a brand new, seasoned non-executive director with intensive NASDAQ audit committee expertise and hope to make a proper announcement shortly”.
This announcement incorporates inside data for the needs of Article 7 of EU Regulation 596/2014.
For additional enquiries:
|Tiziana Life Sciences plc
Gabriele Cerrone, Chairman and founder
|+44 (0)20 7493 2379|
|Cairn Monetary Advisers LLP (Nominated adviser)
Liam Murray / Jo Turner
|+44 (0)20 7213 0880|
|Optiva Securities Restricted (Dealer)
|+ 44 (0)20 3981 4173|
For extra data go to http://www.tizianalifesciences.com